Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03497826
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
SUB | 3-PHENYL-2-{[4-(TOLUENE-4-SULFONYL)- THIOMORPHOLINE-3-CARBONYL]-AMINO}- PROPIONIC ACID ETHYL ESTER | A | 1J4H | 0.72 | |
894 | 2-(5-CHLORO-2-THIENYL)-N-{(3S)- 1-[(1S)-1-METHYL-2-MORPHOLIN-4- YL-2-OXOETHYL]-2-OXOPYRROLIDIN- 3-YL}ETHANESULFONAMIDE | A | 2UWP | 0.71 | |
894 | 2-(5-CHLORO-2-THIENYL)-N-{(3S)- 1-[(1S)-1-METHYL-2-MORPHOLIN-4- YL-2-OXOETHYL]-2-OXOPYRROLIDIN- 3-YL}ETHANESULFONAMIDE | D,H | 2JH6 | 0.71 | |
K7I | L-alanyl-N-[(1S,2R)-1-benzyl-2- hydroxypropyl]-L-alaninamide | A,B | 2QXG | 0.72 | |
PNM | OPEN FORM - PENICILLIN G | A | 1GHP | 0.72 | |
PNM | OPEN FORM - PENICILLIN G | A | 1PWC | 0.72 | |
PNM | OPEN FORM - PENICILLIN G | A | 1IYQ | 0.72 | |
PNM | OPEN FORM - PENICILLIN G | A | 1FQG | 0.72 | |
PNM | OPEN FORM - PENICILLIN G | A,B,C,D | 2J8Y | 0.72 | |
PNM | OPEN FORM - PENICILLIN G | A,B,C,D | 2JBF | 0.72 | |
PNM | OPEN FORM - PENICILLIN G | A | 2EX8 | 0.72 | |
VS1 | 3-[[N-[MORPHOLIN-N-YL]-CARBONYL]- PHENYLALANINYL-AMINO]-5- PHENYL- PENTANE-1-SULFONYLBENZENE | A | 2P86 | 0.7 | |
VS1 | 3-[[N-[MORPHOLIN-N-YL]-CARBONYL]- PHENYLALANINYL-AMINO]-5- PHENYL- PENTANE-1-SULFONYLBENZENE | A,B,C | 1F29 | 0.7 | |
PG1 | PENICILLIN G ACYL-SERINE | A,B | 1XA7 | 0.75 | |
PG1 | PENICILLIN G ACYL-SERINE | A | 2IWC | 0.75 | |
PG1 | PENICILLIN G ACYL-SERINE | A,B | 1MWT | 0.75 | |
701 | (2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)- 1-[(1S)-1-METHYL-2-MORPHOLIN-4- YL-2-OXOETHYL]-2-OXOPYRROLIDIN- 3-YL}PROPENE-1-SULFONAMIDE | D,H | 2JH0 | 0.71 | |
701 | (2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)- 1-[(1S)-1-METHYL-2-MORPHOLIN-4- YL-2-OXOETHYL]-2-OXOPYRROLIDIN- 3-YL}PROPENE-1-SULFONAMIDE | A | 2UWO | 0.71 | |
MQQ | N-[(1S)-1-[({(1S)-3-PHENYL-1-[2- (PHENYLSULFONYL)ETHYL]PROPYL}AMINO)CARBONYL]- 3-(PHENYLSULFONYL)PROPYL]MORPHOLINE- 4-CARBOXAMIDE | A | 2G6D | 0.71 | |
C4P | N-[(1R)-2-(BENZYLSULFANYL)-1-FORMYLETHYL]- N-(MORPHOLIN-4-YLCARBONYL)-L-PHENYLALANINAMIDE | A | 1NQC | 0.71 | |
C1P | N~2~-(MORPHOLIN-4-YLCARBONYL)-N~1~- [(1S,2E)-1-(2-PHENYLETHYL)-3-(PHENYLSULFONYL)PROP- 2-ENYL]-D-LEUCINAMIDE | A,B,C,D | 3BWK | 0.73 | |
C1P | N~2~-(MORPHOLIN-4-YLCARBONYL)-N~1~- [(1S,2E)-1-(2-PHENYLETHYL)-3-(PHENYLSULFONYL)PROP- 2-ENYL]-D-LEUCINAMIDE | A,B | 1NPZ | 0.73 | |
895 | 2-(5-CHLORO-2-THIENYL)-N-{(3S)- 1-[(1S)-1-METHYL-2-MORPHOLIN-4- YL-2-OXOETHYL]-2-OXOPYRROLIDIN- 3-YL}ETHENESULFONAMIDE | D,H | 2JH5 | 0.71 | |
895 | 2-(5-CHLORO-2-THIENYL)-N-{(3S)- 1-[(1S)-1-METHYL-2-MORPHOLIN-4- YL-2-OXOETHYL]-2-OXOPYRROLIDIN- 3-YL}ETHENESULFONAMIDE | A | 2UWL | 0.71 | |
739 | 2(S)-{2(S)-[2(R)-AMINO-3-MERCAPTO]PROPYLAMINO- 3(S)-METHYL}PENTYLOXY-3-PHENYLPROPIONYLMETHIONINE SULFONE | A,B | 1JCQ | 0.7 | |
TZT | SOBLIDOTIN | A,B,C,D | 3E22 | 0.71 | |
CEP | CEPHALOTHIN GROUP | A | 1CEG | 0.71 | |
CEP | CEPHALOTHIN GROUP | A | 1IYP | 0.71 | |
GSB | S-BENZYL-GLUTATHIONE | A,B,C,D | 1FRO | 0.74 | |
GSB | S-BENZYL-GLUTATHIONE | A,B,C,D | 1GUH | 0.74 | |
GBI | S-(3-IODOBENZYL)GLUTATHIONE | A | 2GSQ | 0.72 | |
BCQ | N-[(1R)-1-[({[(5S)-3,5-DIMETHYL- 2,5-DIHYDROISOXAZOL-4-YL]METHYL}SULFONYL)METHYL]- 2-OXO-2-({(1S)-3-PHENYL-1-[2-(PHENYLSULFONYL)ETHYL]PROPYL}AMINO)ETHYL]MORPHOLINE- 4-CARBOXAMIDE | A | 2FYE | 0.71 | |
ZED | L-PROLINE, 1-[(2S)-3-MERCAPTO-2- METHYL-1-OXOPROPYL]-4-(PHENYLTHIO)- , 4S | A | 2EWB | 0.75 | |
GSO | L-GAMMA-GLUTAMYL-S-[(2S)-2-HYDROXY- 2-PHENYLETHYL]-L-CYSTEINYLGLYCINE | A,B,C,D | 2C4J | 0.71 | |
IBG | GAMMA-GLUTAMYL[S-(2-IODOBENZYL)CYSTEINYL]GLYCINE | A | 1M9B | 0.72 | |
TST | 4-METHYL-2-{[4-(TOLUENE-4-SULFONYL)- THIOMORPHOLINE-3-CARBONYL]-AMINO}- PENTANOIC ACID | A | 1J4I | 0.7 |